You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
23 July 2026 - Global biotechnology company Nona Biosciences, a wholly owned subsidiary of HBM Holding Limited (HKEX:02142), announced on Wednesday a research collaboration with the Medical University of Vienna (MedUni Vienna).The collaboration enabl...
23 July 2026 - Biotechnology company Ascletis Pharma Inc (HKEX:1672) announced on Wednesday that preclinical data of ASC36_35 FDC, a once-monthly injection co-formulation of ASC36, a peptide amylin receptor agonist, and ASC35, a peptide GLP-1R/GIPR a...
23 July 2026 - Biopharmaceutical company GSK plc (LON:GSK) (NYSE:GSK) announced on Wednesday that the US Food and Drug Administration (FDA) has approved Jideytro (zidesamtinib), a ROS1 selective inhibitor, for the treatment of adult patients with loc...
22 July 2026 - US biopharmaceutical company Greenwich LifeSciences, Inc. (NASDAQ: GLSI) said on Wednesday it has received regulatory clearance to extend its Phase III FLAMINGO-01 trial into the United Kingdom, enabling the addition of 5–10 UK s...
22 July 2026 - Animal health company Zoetis Inc (NYSE: ZTS) announced on Wednesday that it has launched Portela (relfovetmab) in Canada and European Union member states, introducing the first long-acting anti-nerve growth factor monoclonal antibody t...
22 July 2026 - Elephas Biosciences Corporation, developer of an innovative live tissue platform for immunotherapy response prediction, announced on Tuesday that it has entered into an international partnership with life sciences company Invitrocue Pt...
21 July 2026 - India-based global pharmaceutical company Lupin Limited (BSE: 500257) (NSE: LUPIN) announced on Tuesday the strategic spin-out of two oncology programmes, LNP7457 (PRMT5) and LNP8701 (SOS1), through its wholly owned subsidiary, Lupin I...